Skip over global navigation links
U.S. Department of Health and Human Services

John S. Bradley, M.D., FAAP, FIDSA

National Preparedness and Response Science Board Member

Dr. Bradley completed his Pediatric Infectious Diseases training at Stanford University in 1981 and spends his time divided between clinical medicine and clinical research. His clinical research priorities are the development of effective therapy for both multi-drug resistant Gram-negative bacilli and for CA-MRSA invasive infections, using pharmacodynamic/pharmacokinetic modeling for dose optimization.

He is a Professor and Chief of the Division of Infectious Diseases in the Department of Pediatrics at UCSD, and the Director of the Division of ID at Rady Children's Hospital San Diego. He served on the FDA’s Anti-Infectives Advisory Drug Committee, and continues currently as an Advisor. He joined the NBSB in 2011. He has worked with the CDC and AAP on a joint Anthrax Clinical Report, as well as being a member of the Working Group for the ASPR/Keystone collaboration to create the Botulism/Botulinum Intoxication Clinical Guidance.

Photograph of John S. Bradley, M.D., FAAP, FIDSA

He is a Section Editor (Antimicrobial Reviews) for the Pediatric Infectious Diseases Journal, and sits on the editorial board of the Journal of the Pediatric Infectious Diseases Society. He is also the co-editor of the AAP’s Nelson’s Pediatric Antimicrobial Therapy book, with John Nelson.

National Preparedness and Response Science Board

For further questions or comments on the National Biodefense Science Board, please contact us via the National Preparedness and Response Science Board Contact Form.

  • This page last reviewed: January 27, 2015